Ribostamycin sulfate
- Level
- Commodity
- Parent
- 51281600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51281664This classification denotes an aminoglycoside antibiotic C17H34N4O10.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QFN1QU7PEN, chemically known as o-2,6-diamino-2,6-dideoxy-.alpha.-d-glucopyranosyl-(1->4)-o-(.beta-d-ribofuranosyl-(1->5))-2-deoxy-d-streptamine sulfate, but more generally known as ribostamycin sulfate, which bears US NIH Compound Identifier 5702279. European Medicines Agency schedules in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04244MIG. Most nations, for tariff and trade purposes, schedule ribostamycin sulfate under HS 29419000 and SITC 54139. As of Q4 2014, RIBOSTAMYCIN SULFATE remains US FDA's Preferred Term for this commodity. SMILES: C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)O)N.OS(=O)(=O)O.
Same parent
Under 51281600 · 75Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.